215 related articles for article (PubMed ID: 28591699)
1. Genetic heterogeneity in leiomyomas of deep soft tissue.
Panagopoulos I; Gorunova L; Brunetti M; Agostini A; Andersen HK; Lobmaier I; Bjerkehagen B; Heim S
Oncotarget; 2017 Jul; 8(30):48769-48781. PubMed ID: 28591699
[TBL] [Abstract][Full Text] [Related]
2. Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12).
Panagopoulos I; Gorunova L; Bjerkehagen B; Heim S
PLoS One; 2015; 10(4):e0124288. PubMed ID: 25875009
[TBL] [Abstract][Full Text] [Related]
3. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.
Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
[TBL] [Abstract][Full Text] [Related]
4. Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21).
Panagopoulos I; Gorunova L; Bjerkehagen B; Heim S
PLoS One; 2015; 10(1):e0117010. PubMed ID: 25621995
[TBL] [Abstract][Full Text] [Related]
5. Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models.
Klemke M; Müller MH; Wosniok W; Markowski DN; Nimzyk R; Helmke BM; Bullerdiek J
PLoS One; 2014; 9(2):e88126. PubMed ID: 24516594
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
[TBL] [Abstract][Full Text] [Related]
7. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ
Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224
[TBL] [Abstract][Full Text] [Related]
8. Paratesticular leiomyoma with a der(14)t(12;14)(q15;q24).
Gorunova L; Bjerkehagen B; Heim S
Cancer Genet; 2011 Aug; 204(8):465-8. PubMed ID: 21962898
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
[TBL] [Abstract][Full Text] [Related]
10. Uterine leiomyoma cytogenetics.
Nibert M; Heim S
Genes Chromosomes Cancer; 1990 May; 2(1):3-13. PubMed ID: 2278965
[TBL] [Abstract][Full Text] [Related]
11. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
12. HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality.
Hennig Y; Rogalla P; Wanschura S; Frey G; Deichert U; Bartnitzke S; Bullerdiek J
Cancer Genet Cytogenet; 1997 Jul; 96(2):129-33. PubMed ID: 9216720
[TBL] [Abstract][Full Text] [Related]
13. Fusion of HMGA2 to COG5 in uterine leiomyoma.
Velagaleti GV; Tonk VS; Hakim NM; Wang X; Zhang H; Erickson-Johnson MR; Medeiros F; Oliveira AM
Cancer Genet Cytogenet; 2010 Oct; 202(1):11-6. PubMed ID: 20804914
[TBL] [Abstract][Full Text] [Related]
14. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
[TBL] [Abstract][Full Text] [Related]
16. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.
Mehine M; Kaasinen E; Heinonen HR; Mäkinen N; Kämpjärvi K; Sarvilinna N; Aavikko M; Vähärautio A; Pasanen A; Bützow R; Heikinheimo O; Sjöberg J; Pitkänen E; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1315-20. PubMed ID: 26787895
[TBL] [Abstract][Full Text] [Related]
17. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
[TBL] [Abstract][Full Text] [Related]
18. 6p21 rearrangements in uterine leiomyomas targeting HMGA1.
Nezhad MH; Drieschner N; Helms S; Meyer A; Tadayyon M; Klemke M; Belge G; Bartnitzke S; Burchardt K; Frantzen C; Schmidt EH; Bullerdiek J
Cancer Genet Cytogenet; 2010 Dec; 203(2):247-52. PubMed ID: 21156240
[TBL] [Abstract][Full Text] [Related]
19. Fusion of the
Panagopoulos I; Andersen K; Gorunova L; Davidson B; Micci F; Heim S
In Vivo; 2022; 36(6):2654-2661. PubMed ID: 36309352
[TBL] [Abstract][Full Text] [Related]
20. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2001 Sep; 25(9):1134-42. PubMed ID: 11688572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
